U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology

Cisco Systems, Inc. CSCO	0.00	0.00%
GOOSEHEAD INSURANCE, INC. GSHD	0.00	0.00%
Helios Technologies, Inc. HLIO	0.00	0.00%
Tango Therapeutics TNGX	0.00	0.00%
Amgen Inc. AMGN	0.00	0.00%

May 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cisco, DTE Energy and Marvell Technology on Thursday.

HIGHLIGHTS

* Cheesecake Factory Inc CAKE.O: JP Morgan raises to neutral from underweight

* Cisco CSCO.O: Evercore ISI raises target price to $150 from $110

* DTE Energy Co DTE.N: JP Morgan cuts target price to $155 from $160

* Marvell Technology Inc MRVL.O: RBC raises target price to $200 from $170

* WEC Energy Group Inc WEC.N: JP Morgan cuts target price to $120 from $125

Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.

* AbbVie ABBV.N: Piper Sandler raises target price to $298 from $294

* Ameren Corp AEE.N: JP Morgan cuts target price to $120 from $123

* Amgen Inc AMGN.O: Piper Sandler cuts target price to $427 from $432

* Aramark ARMK.N: Jefferies raises target price to $58 from $47

* Aramark ARMK.N: RBC raises target price to $55 from $47

* Arvinas Inc ARVN.O: Leerink Partners cuts target price to $9 from $18

* Cheesecake Factory Inc CAKE.O: JP Morgan raises to neutral from underweight

* Cheesecake Factory Inc CAKE.O: JP Morgan raises target price to $68 from $58

* Cisco CSCO.O: Evercore ISI raises target price to $150 from $110

* Cisco CSCO.O: Melius Research raises target price to $145 from $100

* Cisco CSCO.O: Morgan Stanley raises target price to $120 from $91

* Cisco CSCO.O: Piper Sandler raises target price to $132 from $86

* CMS Energy Corp CMS.N: JP Morgan cuts target price to $82 from $86

* Compass Minerals International Inc CMP.N: JP Morgan raises to neutral from underweight

* Compass Minerals International Inc CMP.N: JP Morgan raises PT to $30 from $20

* Damora Therapeutics Inc DMRA.O: Leerink Partners cuts target price to $51 from $55

* Doximity Inc DOCS.N: JP Morgan cuts target price to $28 from $33

* DTE Energy Co DTE.N: JP Morgan cuts target price to $155 from $160

* Dynatrace Inc DT.N: JP Morgan cuts target price to $45 from $50

* Dynatrace Inc DT.N: Piper Sandler cuts target price to $40 from $45

* Dynatrace Inc DT.N: RBC cuts target price to $45 from $50

* Goosehead Insurance Inc GSHD.O: JP Morgan cuts target price to $55 from $58

* Helios Technologies Inc HLIO.N: Stifel raises target price to $89 from $80

* Jack In the Box Inc JACK.O: RBC cuts target price to $16 from $17

* Jack In the Box Inc JACK.O: Stifel raises target price to $15 from $10

* Karman Holdings Inc KRMN.N: RBC cuts target price to $100 from $125

* Main Street Capital Corp MAIN.N: RBC cuts target price to $58 from $66

* Marvell Technology Inc MRVL.O: RBC raises target price to $200 from $170

* Mirum Pharmaceuticals Inc MIRM.O: Leerink Partners raises PT to $154 from $150

* Molina Healthcare Inc MOH.N: Jefferies raises target price to $180 from $170

* National Health Investors Inc NHI.N: Jefferies cuts target price to $74 from $83

* National Vision Holdings Inc EYE.O: Barclays cuts target price to $27 from $38

* Staar Surgical Co STAA.O: Canaccord Genuity raises target price to $32 from $27

* Staar Surgical Co STAA.O: Piper Sandler raises target price to $33 from $16

* Tango Therapeutics TNGX.O: Jefferies cuts to hold from buy; raises PT to $27 from $18

* Texas Roadhouse Inc TXRH.O: JP Morgan raises target price to $188 from $182

* US Foods Holding Corp USFD.N: JP Morgan cuts target price to $90 from $98

* US Physical Therapy Inc USPH.N: JP Morgan cuts target price to $90 from $100

* Vishay Intertechnology Inc VSH.N: JP Morgan raises target price to $40 from $20

* WEC Energy Group Inc WEC.N: JP Morgan cuts target price to $120 from $125

* Weyerhaeuser Co WY.N: JP Morgan cuts target price to $30 from $32

* Xcel Energy XEL.O: JP Morgan cuts target price to $91 from $94

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.